Reports
Sale
Global Fertility Supplements Market Size, Share, Trends, Growth: By Ingredient Type: Natural, Synthetic/Blend of Natural & Synthetic; By Product Type: Capsules, Tablets, Soft gels, Powders, Liquids; By Procedure: IVF with ICSI, IUI, Surrogacy, Others; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Fertility Supplements Market Outlook
The global fertility supplements market value in 2023 was USD 1.93 billion driven by the increasing awareness about fertility issues, rising infertility rates across the globe. The market size is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to achieve a value of USD 3.95 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is being supported by the declining fertility rates owing to the changes in lifestyle, including the rising consumption of cigarettes and alcohol. The increasing geriatric population, healthcare costs, and medical discoveries have helped in the growth of the overall fertility supplements industry.
Market Segmentation
The global fertility supplements market can be divided based on segments like products, ingredients, distributional channels, and end-uses.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on its products, the industry is segmented into:
- Capsules
- Tablets
- Soft Gels
- Powder
- Liquids
Based on ingredients, the industry is categorised as natural ingredients and synthetic/blend of synthetic and natural ingredients. Based on distributional channels, the industry is categorised as OTC and prescribed. Based on its end-use segments, the industry is bifurcated into men and women.
The EMR report looks into the regional fertility supplements markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Market Analysis
The growing adoption of herbal medicines (botanicals) due to the increasing concerns about the harmful impacts associated with the traditional pharmaceutical drugs is expected to generate new opportunities for the fertility supplements manufacturers, leading to the growth of the fertility supplements industry. Various public initiatives to raise awareness regarding advancements in fertility supplements among consumers and its superior technology have helped the industry gain a further boost. On the other hand, the increasing significance of food products such as avocados, olive oil, whole grains, and high-fat dairy products to increase fertility is anticipated to aid the functional foods and drinks sector, which may hinder the growth of the global fertility supplements industry over the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global fertility supplements market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Fairhaven Health
- Coast Science
- Lenus Pharma GesmbH
- Active Bio Life Science GmbH
- Orthomol
- Exeltis USA, Inc.
- PregPrep LLC
- Bionova
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report:
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Ingredient Type |
|
| Breakup by Product Type |
|
| Breakup by Procedure |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Fertility Supplements Market Overview
3.1 Global Fertility Supplements Market Historical Value (2017-2023)
3.2 Global Fertility Supplements Market Forecast Value (2024-2032)
4 Global Fertility Supplements Market Landscape
4.1 Global Fertility Supplements Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Fertility Supplements Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Global Fertility Supplements Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Fertility Supplements Market Segmentation
6.1 Global Fertility Supplements Market by Ingredient Type
6.1.1 Market Overview
6.1.2 Natural
6.1.3 Synthetic/Blend of Natural & Synthetic
6.2 Global Fertility Supplements Market by Product Type
6.2.1 Market Overview
6.2.2 Capsules
6.2.3 Tablets
6.2.4 Soft gels
6.2.5 Powders
6.2.6 Liquids
6.3 Global Fertility Supplements Market by Procedure
6.3.1 Market Overview
6.3.2 IVF with ICSI
6.3.3 IUI
6.3.4 Surrogacy
6.3.5 IVF without ICSI
6.3.6 Others
6.4 Global Fertility Supplements Market by End User
6.4.1 Market Overview
6.4.2 Fertility Clinics
6.4.3 Hospitals
6.4.4 Surgical Centers
6.4.5 Clinical Research Institutes
6.4.6 Others
6.5 Global Fertility Supplements Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Over The Counter (OTC)
6.5.3 Prescribed
6.6 Global Fertility Supplements Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Fertility Supplements Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Fertility Supplements Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Fertility Supplements Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Fertility Supplements Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Fertility Supplements Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 CARE Fertility
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Xytex Corporation
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 FUJIFILM Irvine Scientific
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 INVO Bioscience
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 ALABAMA FERTILITY
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Shivani Scientific
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 IVFtech Aps
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 WebMD LLC
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Coast Science
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Ocean Healthcare Private Limited
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Genea Limited
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Medicover AB
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 Monash IVF Australia
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Progyny, Inc
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 Apollo Fertility
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
18.16 Carolinas Fertility Institute
18.16.1 Financial Analysis
18.16.2 Product Portfolio
18.16.3 Demographic Reach and Achievements
18.16.4 Mergers and Acquisitions
18.16.5 Certifications
18.17 Bayer AG
18.17.1 Financial Analysis
18.17.2 Product Portfolio
18.17.3 Demographic Reach and Achievements
18.17.4 Mergers and Acquisitions
18.17.5 Certifications
18.18 Zenith Nutrition
18.18.1 Financial Analysis
18.18.2 Product Portfolio
18.18.3 Demographic Reach and Achievements
18.18.4 Mergers and Acquisitions
18.18.5 Certifications
18.19 SUPPLEMENA
18.19.1 Financial Analysis
18.19.2 Product Portfolio
18.19.3 Demographic Reach and Achievements
18.19.4 Mergers and Acquisitions
18.19.5 Certifications
19 Global Fertility Supplements Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
It is estimated that the global market for fertility supplements reached a value of USD 1.93 billion in 2023.
The market is forecasted to grow at a CAGR 8.3% during the forecast period of 2024-2032 to reach a value of USD 3.95 billion by 2032.
The industry is being aided by changes in lifestyle such as smoking, increased alcohol consumption, dropping fertility rates, growing senior population, and rising healthcare expenditures.
Key trends like the acceptance of herbal medicines (botanicals) and various public campaigns to enhance consumer knowledge are expected to boost the market.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The major products in the industry are capsules, tablets, soft gels, powder, and liquids.
Based on ingredients, the industry is categorised as natural ingredients and synthetic/blend of synthetic and natural ingredients.
The leading distribution channels in the market are OTC and prescribed.
The various end uses of the product are men and women.
The major players in the industry are Fairhaven Health, Coast Science, LLC, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc., and Bionova Lifesciences, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER